TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
about
Emerging Functions of RANKL in Lymphoid TissuesBiology of RANK, RANKL, and osteoprotegerinGenomic amplification of a decoy receptor for Fas ligand in lung and colon cancerBAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growthB cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosisAPRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growthReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisRANK is essential for osteoclast and lymph node developmentA comprehensive manually curated reaction map of RANKL/RANK-signaling pathwayControl of RANKL gene expressionActivated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLOsteoimmunology: interactions of the bone and immune systemIdentification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiationA novel member of the leukocyte receptor complex regulates osteoclast differentiationOsteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLEnhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesisBone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.The molecular mechanism of osteoclastogenesis in rheumatoid arthritisCaldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and functionPaget's disease of bone: an osteoimmunological disorder?Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsA review of denosumab for the treatment of osteoporosisDendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection.Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificityCrystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolutionRANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy ReceptorDC-STAMP: A Key Regulator in Osteoclast DifferentiationReceptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinaseActivation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motifIdentification of a receptor for BLyS demonstrates a crucial role in humoral immunityIdentification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinaseCatalytic properties of ADAM19MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formationCharacterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinaseRole of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling systemAltered bone remodeling in psoriatic arthritisDisorders of bone remodeling
P2860
Q21131222-07AB751E-1D72-4CB9-B473-AB3E424F32FCQ21195419-B7B84954-4740-4651-B648-49191395955FQ22008593-E1D94B8B-07EF-4F51-8309-728AC98CC37BQ22009942-6336CAFC-C6A9-4802-B0AD-F9E29D774FFDQ22254659-A7E24B0E-A132-4F2E-AD05-51B4EC767913Q24312907-81B669CD-7052-4926-B577-FC4258805871Q24315058-96568726-ECB7-42BB-9228-D1153D441F1DQ24537518-1220FDD0-430F-42FF-8B5F-FE34B4E78FC9Q24563235-E08E75CA-F4B1-4985-8F56-C981963820EBQ24598872-AF11B548-E8EC-4DFD-A18C-02CC87986443Q24599024-B0956E60-F28C-451E-B28B-64B662577C58Q24619669-DC636BE6-02A8-4CDB-A7D5-5165CF0F08C7Q24632345-2FE1646C-5372-4248-82E5-7BCE5E6E8BB0Q24655113-21461BB1-1B03-4F08-A2D0-59D940B04678Q24657159-D640CC14-EC1B-4837-B46E-23818034E085Q24675157-571E3622-FDA2-4B73-89CA-05AE7CDACE75Q24682139-90EA2B2A-AC38-49AC-8C95-DED2A0DCB835Q24800726-49A15FF6-9D63-449C-8DC6-A321ACBB8A2DQ24805142-E8271FCD-A5E2-4A9D-94CC-AF3FF7CD5348Q24805207-6F238E6C-118C-4CCE-9BEB-5048DE20D023Q24806322-07CE0358-4889-41F8-BFFD-70FC75CE3336Q26775406-0856816B-F759-472E-AFEB-BDEC61B72C34Q26796458-D7B9DE24-BB69-4B1C-BC6C-45A8093B2FCAQ26824762-4501277C-164C-469D-AA7A-0F29D07460BCQ27005894-BFB8C526-9C95-426E-86D0-9D87AB3B0F5DQ27469822-D0E34488-8891-4AC6-93BB-6B3E71606150Q27635130-CAACE7E8-7C9E-483C-A334-F7563740D5EDQ27636573-F5E66DCA-1320-49BA-AC75-3BCAABC62322Q27674275-0D2BDB1A-4FD8-4CF1-B1D4-B85183F436A9Q28079466-F8FCFD4E-99AA-4BF8-B0AD-0826F56FCDB3Q28137640-6565BB1B-30A3-49FA-9744-4FB107BC6CE2Q28138697-BBF114F2-E33F-438A-ADBA-CB77F790E5EEQ28139967-A8C989EC-C084-4DC2-B1A8-6C5861D092C2Q28144774-425A7558-BD0B-40DA-939E-A2E3B348FC23Q28189426-298B765F-62DC-4A45-80C7-C9B9B0632A69Q28236005-4EF9CD3F-09FF-415B-BB87-E6EA28430996Q28278061-68953DE2-8B79-4968-8FE3-CE5EFFA42185Q28283972-9B7A02F5-DF05-4220-B42C-AF571B0DEEDEQ28288855-B1773638-228C-46EC-9295-6C17BFEE047EQ28295303-F0CC4ECE-CCCE-416A-B943-3ACF9A73C726
P2860
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@ast
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en-gb
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@nl
type
label
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@ast
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en-gb
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@nl
prefLabel
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@ast
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en-gb
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@nl
P2093
P2860
P356
P1476
TRANCE is a novel ligand of th ...... n N-terminal kinase in T cells
@en
P2093
E Robinson
F S Bartlett
J Orlinick
S Kalachikov
W N Frankel
P2860
P304
25190-25194
P356
10.1074/JBC.272.40.25190
P407
P577
1997-10-01T00:00:00Z